-
1
-
-
0034469464
-
Macrophages in rheumatoid arthritis
-
DOI 10.1186/ar86
-
Kinne, R. W.; Brauer, R.; Stuhlmuller, B.; Palombo-Kinne, E.; Burmester, G. Macrophages in rheumatoid arthritis Arthritis Res. 2000, 2, 189-202 (Pubitemid 32223726)
-
(2000)
Arthritis Research
, vol.2
, Issue.3
, pp. 189-202
-
-
Kinne, R.W.1
Brauer, R.2
Stuhlmuller, B.3
Palombo-Kinne, E.4
Burmester, G.-R.5
-
3
-
-
67649400529
-
Recent development in CCR2 antagonists
-
Xia, M.; Sui, Z. Recent development in CCR2 antagonists Expert Opin. Ther. Pat. 2009, 19, 295-303
-
(2009)
Expert Opin. Ther. Pat.
, vol.19
, pp. 295-303
-
-
Xia, M.1
Sui, Z.2
-
4
-
-
67649425653
-
Chemokine receptor antagonists: Part i
-
Pease, J. E.; Horuk, R. Chemokine receptor antagonists: Part I Expert Opin. Ther. Pat. 2009, 19, 39-58
-
(2009)
Expert Opin. Ther. Pat.
, vol.19
, pp. 39-58
-
-
Pease, J.E.1
Horuk, R.2
-
6
-
-
77956621678
-
Discovery of a potent and orally bioavailable CCR2 and CCR5 dual antagonist
-
Pasternak, A.; Goble, S. D.; Struthers, M.; Vicario, P. P.; Ayala, J. M.; Di Salvo, J.; Kilburn, R.; Wisniewski, T.; DeMartino, J. A.; Mills, S. G.; Yang, L. Discovery of a potent and orally bioavailable CCR2 and CCR5 dual antagonist ACS Med. Chem. Lett. 2010, 1, 14-18
-
(2010)
ACS Med. Chem. Lett.
, vol.1
, pp. 14-18
-
-
Pasternak, A.1
Goble, S.D.2
Struthers, M.3
Vicario, P.P.4
Ayala, J.M.5
Di Salvo, J.6
Kilburn, R.7
Wisniewski, T.8
Demartino, J.A.9
Mills, S.G.10
Yang, L.11
-
7
-
-
77950042517
-
γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
-
Cherney, R. J.; Mo, R.; Meyer, D. T.; Voss, M. E.; Yang, M. G.; Santella, J. B., III; Duncia, J. V.; Lo, Y. C.; Yang, G.; Miller, P. B.; Scherle, P. A.; Zhao, Q.; Mandlekar, S.; Cvijic, M. E.; Barrish, J. C.; Decicco, C. P.; Carter, P. H. γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists Bioorg. Med. Chem. Lett. 2010, 20, 2425-2430
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 2425-2430
-
-
Cherney, R.J.1
Mo, R.2
Meyer, D.T.3
Voss, M.E.4
Yang, M.G.5
Santella III, J.B.6
Duncia, J.V.7
Lo, Y.C.8
Yang, G.9
Miller, P.B.10
Scherle, P.A.11
Zhao, Q.12
Mandlekar, S.13
Cvijic, M.E.14
Barrish, J.C.15
Decicco, C.P.16
Carter, P.H.17
-
8
-
-
77954312019
-
Identification of a sulfonamide series of CCR2 antagonists
-
Peace, S.; Philp, J.; Brooks, C.; Piercy, V.; Moores, K.; Smethurst, C.; Watson, S.; Gaines, S.; Zippoli, M.; Mookherjee, C.; Ife, R. Identification of a sulfonamide series of CCR2 antagonists Bioorg. Med. Chem. Lett. 2010, 20, 3961-3964
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 3961-3964
-
-
Peace, S.1
Philp, J.2
Brooks, C.3
Piercy, V.4
Moores, K.5
Smethurst, C.6
Watson, S.7
Gaines, S.8
Zippoli, M.9
Mookherjee, C.10
Ife, R.11
-
9
-
-
78549245467
-
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
-
Xue, C.-B.; Wang, A.; Meloni, D.; Zhang, K.; Kong, L.; Feng, H.; Glenn, J.; Huang, T.; Zhang, Y.; Cao, G.; Anand, R.; Zheng, C.; Xia, M.; Han, Q.; Robinson, D. J.; Storace, L.; Shao, L.; Li, M.; Brodmerkel, C. M.; Covington, M.; Scherle, P.; Diamond, S.; Yeleswaram, S; Vaddi, K.; Newton, R.; Hollis, G.; Friedman, S.; Metcalf, B. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2 Bioorg. Med. Chem. Lett. 2010, 20, 7473-7478
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 7473-7478
-
-
Xue, C.-B.1
Wang, A.2
Meloni, D.3
Zhang, K.4
Kong, L.5
Feng, H.6
Glenn, J.7
Huang, T.8
Zhang, Y.9
Cao, G.10
Anand, R.11
Zheng, C.12
Xia, M.13
Han, Q.14
Robinson, D.J.15
Storace, L.16
Shao, L.17
Li, M.18
Brodmerkel, C.M.19
Covington, M.20
Scherle, P.21
Diamond, S.22
Yeleswaram, S.23
Vaddi, K.24
Newton, R.25
Hollis, G.26
Friedman, S.27
Metcalf, B.28
more..
-
10
-
-
79951725766
-
Discovery of INCB10820/PF-4178903, a potent, selective and orally bioavailable dual CCR2 and CCR5 antagonist
-
Zheng, C.; Cao, G.; Xia, M.; Feng, H.; Glenn, J.; Anand, R.; Zhang, K.; Huang, T.; Wang, A.; Kong, L.; Li, M.; Galya, L.; Hughes, R. O.; Devraj, R.; Morton, P. A.; Rogier, D. J.; Covington, M.; Baribaud, F.; Shin, N.; Scherle, P.; Diamond, S.; Yeleswaram, S.; Vaddi, K.; Newton, R.; Hollis, G.; Friedman, S.; Metcalf, B.; Xue, C.-B. Discovery of INCB10820/PF-4178903, a potent, selective and orally bioavailable dual CCR2 and CCR5 antagonist Bioorg. Med. Chem. Lett. 2011, 21, 1442-1446
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 1442-1446
-
-
Zheng, C.1
Cao, G.2
Xia, M.3
Feng, H.4
Glenn, J.5
Anand, R.6
Zhang, K.7
Huang, T.8
Wang, A.9
Kong, L.10
Li, M.11
Galya, L.12
Hughes, R.O.13
Devraj, R.14
Morton, P.A.15
Rogier, D.J.16
Covington, M.17
Baribaud, F.18
Shin, N.19
Scherle, P.20
Diamond, S.21
Yeleswaram, S.22
Vaddi, K.23
Newton, R.24
Hollis, G.25
Friedman, S.26
Metcalf, B.27
Xue, C.-B.28
more..
-
11
-
-
79959248212
-
Discovery of INCB3284, a potent, selective and orally bioavailable hCCR2 antagonist
-
Xue, C.-B.; Feng, H.; Cao, G.; Huang, T.; Glenn, J.; Anand, R.; Meloni, D.; Zhang, K.; Kong, L.; Wang, A.; Zhang, Y.; Zheng, C.; Xia, M.; Chen, L.; Tanaka, H.; Han, Q.; Robinson, D. J.; Modi, D.; Storace, L.; Shao, L.; Sharief, V.; Li, M.; Covington, M.; Scherle, P.; Diamond, S.; Emm, T.; Yeleswaram, S.; Contel, N.; Vaddi, K.; Newton, R.; Hollis, G.; Friedman, S.; Metcalf, B. Discovery of INCB3284, a potent, selective and orally bioavailable hCCR2 antagonist ACS Med. Chem. Lett. 2011, 2, 450-454
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 450-454
-
-
Xue, C.-B.1
Feng, H.2
Cao, G.3
Huang, T.4
Glenn, J.5
Anand, R.6
Meloni, D.7
Zhang, K.8
Kong, L.9
Wang, A.10
Zhang, Y.11
Zheng, C.12
Xia, M.13
Chen, L.14
Tanaka, H.15
Han, Q.16
Robinson, D.J.17
Modi, D.18
Storace, L.19
Shao, L.20
Sharief, V.21
Li, M.22
Covington, M.23
Scherle, P.24
Diamond, S.25
Emm, T.26
Yeleswaram, S.27
Contel, N.28
Vaddi, K.29
Newton, R.30
Hollis, G.31
Friedman, S.32
Metcalf, B.33
more..
|